146 related articles for article (PubMed ID: 30035467)
1. [Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Nihon Jibiinkoka Gakkai Kaiho; 2017 Jan; 120(1):44-51. PubMed ID: 30035467
[TBL] [Abstract][Full Text] [Related]
2. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
[TBL] [Abstract][Full Text] [Related]
3. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Arerugi; 2016; 65(9):1209-1218. PubMed ID: 27885205
[TBL] [Abstract][Full Text] [Related]
4. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Arerugi; 2015 Dec; 64(10):1323-33. PubMed ID: 26727137
[TBL] [Abstract][Full Text] [Related]
5. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
7. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
[TBL] [Abstract][Full Text] [Related]
8. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
9. [CLINICAL EFFICACY OF 69 PATIENTS WITH JAPANESE CEDAR POLLINOSIS TREATED BY SUBLINGUAL IMMUNOTHERAPY WITH CEDARCURE
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
Arerugi; 2019; 68(8):958-965. PubMed ID: 31534107
[TBL] [Abstract][Full Text] [Related]
10. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
[TBL] [Abstract][Full Text] [Related]
11. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
[TBL] [Abstract][Full Text] [Related]
12. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
Yuta A; Ogawa Y; Kozaki H; Shimizu T
Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
16. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN A LARGE AMOUNT OF POLLEN DISPARSAL AND IT'S IMPACT OF TREATMENT YEAR].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Ohta N; Shimizu T
Arerugi; 2018; 67(8):1011-1019. PubMed ID: 30249950
[TBL] [Abstract][Full Text] [Related]
17. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
[TBL] [Abstract][Full Text] [Related]
18. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
19. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Takeda N
J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
